Decline in childhood measles vaccine has health and economic consequences

vaccine
A study outlines the public health and economic consequences when children aren't vaccinated against measles.

Even a minor drop in the number of children vaccinated against measles can have substantial public health and economic consequences, according to a new study.

The results directly confront the idea that measles is no longer a health threat in the United States and demonstrate what happens when states allow nonmedical personal belief exemptions for childhood vaccinations.

Researchers estimated that even a 5% decline in children ages 2 to 11 receiving the MMR (measles, mumps and rubella) vaccination would result in an estimated threefold increase in national measles cases in those kids, according to the study published in JAMA Pediatrics. The result would have consequences for both public health and costs: A total of 150 cases of measles and an additional $2.1 million in costs.

Conference

2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

The size of the outbreaks increased with declining vaccination coverage, according to the results.

The United States saw an outbreak of measles in Minnesota earlier this year, with more cases there than in the entire country last year. The majority of people who got measles were not vaccinated. Hundreds of cases of mumps were also reported across the country since the start of 2017.

RELATED: Anti-vaccine movement fears grow as Trump takes office

The study estimated the number of measles cases in U.S. children and the associated economic costs under different scenarios where vaccines were either delayed or refused because of nonmedical personal beliefs.

Two researchers, Nathan C. Lo, of the Stanford University School of Medicine in California, and Peter J. Hotez, M.D., of the Baylor College of Medicine in Houston, used data from the Centers for Disease Control and Prevention to simulate county-level MMR vaccination coverage. They then used a mathematical model for infectious disease transmission to estimate distribution of an outbreak. They based the economic costs per measles case on published literature.

“The results of our study find substantial public health and economic consequences with even minor reductions in MMR coverage due to vaccine hesitancy and directly confront the notion that measles is no longer a threat in the United States,” the authors wrote.

“Removal of the nonmedical personal belief exemptions for childhood vaccination may mitigate these consequences. These findings should play a key role in any policies adapted by state or national governments that relate to childhood vaccination,” the study concluded.

The election of President Donald Trump had some scientists worried about reports he planned to establish a panel on vaccine safety which could cause some people to refuse protective immunizations, leading to epidemics of highly contagious diseases.

Those fears were renewed when the White House in April dismissed U.S. Surgeon General Vivek H. Murthy, who was vocal in his support of the value of childhood vaccines.

During his campaign, Trump voiced concerns about the safety and timing of vaccines, giving credence to the antivaccine movement. Before taking office, Trump met with vaccine skeptic Robert F. Kennedy Jr., who said he talked to Trump about chairing a committee to study vaccine safety.

Suggested Articles

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

Two lawsuits were filed suing the Trump administration to overturn a new rule that would allow healthcare workers to deny care over religious or conscience…

Blue Shield of California has teamed up with Landmark Health to offer more home health visits to members with chronic conditions.